Brenner and transitional cell tumours of the ovary. Report of three cases. 1994

V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
Department of Obstetrics and Gynaecology, Turku University Central Hospital, Finland.

Three rare epithelial ovarian tumours, one malignant Brenner tumour, one transitional cell carcinoma and one Brenner tumour of borderline malignancy, are presented with special emphasis on the diagnostic, prognostic and therapeutic modalities. Because the prognosis of transitional cell carcinoma of the ovary is worse, as in our case, than that of the malignant Brenner tumour, this classification is justified.

UI MeSH Term Description Entries
D010051 Ovarian Neoplasms Tumors or cancer of the OVARY. These neoplasms can be benign or malignant. They are classified according to the tissue of origin, such as the surface EPITHELIUM, the stromal endocrine cells, and the totipotent GERM CELLS. Cancer of Ovary,Ovarian Cancer,Cancer of the Ovary,Neoplasms, Ovarian,Ovary Cancer,Ovary Neoplasms,Cancer, Ovarian,Cancer, Ovary,Cancers, Ovarian,Cancers, Ovary,Neoplasm, Ovarian,Neoplasm, Ovary,Neoplasms, Ovary,Ovarian Cancers,Ovarian Neoplasm,Ovary Cancers,Ovary Neoplasm
D010053 Ovary The reproductive organ (GONADS) in female animals. In vertebrates, the ovary contains two functional parts: the OVARIAN FOLLICLE for the production of female germ cells (OOGENESIS); and the endocrine cells (GRANULOSA CELLS; THECA CELLS; and LUTEAL CELLS) for the production of ESTROGENS and PROGESTERONE. Ovaries
D011003 Ploidies The degree of replication of the chromosome set in the karyotype. Ploidy
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D011980 Receptors, Progesterone Specific proteins found in or on cells of progesterone target tissues that specifically combine with progesterone. The cytosol progesterone-receptor complex then associates with the nucleic acids to initiate protein synthesis. There are two kinds of progesterone receptors, A and B. Both are induced by estrogen and have short half-lives. Progesterone Receptors,Progestin Receptor,Progestin Receptors,Receptor, Progesterone,Receptors, Progestin,Progesterone Receptor,Receptor, Progestin
D001948 Brenner Tumor A smooth, solid or cystic fibroepithelial (FIBROEPITHELIAL NEOPLASMS) tumor, usually found in the OVARIES but can also be found in the adnexal region and the KIDNEYS. It consists of a fibrous stroma with nests of epithelial cells that sometimes resemble the transitional cells lining the urinary bladder. Brenner tumors generally are benign and asymptomatic. Malignant Brenner tumors have been reported. Benign Brenner Tumor,Brenner Tumor of Ovary,Malignant Brenner Tumor,Ovarian Brenner Tumor,Proliferative Brenner Tumor,Brenner Tumor, Benign,Brenner Tumor, Malignant,Brenner Tumor, Proliferative,Ovary Brenner Tumor
D002295 Carcinoma, Transitional Cell A malignant neoplasm derived from TRANSITIONAL EPITHELIAL CELLS, occurring chiefly in the URINARY BLADDER; URETERS; or RENAL PELVIS. Carcinomas, Transitional Cell,Cell Carcinoma, Transitional,Cell Carcinomas, Transitional,Transitional Cell Carcinoma,Transitional Cell Carcinomas
D003131 Combined Modality Therapy The treatment of a disease or condition by several different means simultaneously or sequentially. Chemoimmunotherapy, RADIOIMMUNOTHERAPY, chemoradiotherapy, cryochemotherapy, and SALVAGE THERAPY are seen most frequently, but their combinations with each other and surgery are also used. Multimodal Treatment,Therapy, Combined Modality,Combined Modality Therapies,Modality Therapies, Combined,Modality Therapy, Combined,Multimodal Treatments,Therapies, Combined Modality,Treatment, Multimodal,Treatments, Multimodal
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005260 Female Females

Related Publications

V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 2007, Akusherstvo i ginekologiia,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 1981, Diagnostic gynecology and obstetrics,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 1969, Acta obstetricia et gynecologica Scandinavica,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 1972, Acta pathologica et microbiologica Scandinavica. Supplement,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 1957, Cancer,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
June 1956, The Journal of obstetrics and gynaecology of the British Empire,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
September 1990, Zhonghua bing li xue za zhi = Chinese journal of pathology,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
February 1956, The Journal of obstetrics and gynaecology of the British Empire,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
January 1987, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
V Rantanen, and S Grénman, and P Kiilholma, and T Salmi, and P J Klemi
October 1953, The Journal of pathology and bacteriology,
Copied contents to your clipboard!